Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 1 · 33.3%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

All‐cause short‐term mortality: 1 month · adults with cardiogenic shock or low cardiac output syndrome

The review found no eligible studies for this question.

1 finding from 1 review

All‐cause short‐term mortality: 30 days · adults with cardiogenic shock

It is very uncertain whether levosimendan changes all‐cause short‐term mortality: 30 days compared with enoximone (very low certainty).

1 finding from 1 review

All‐cause short‐term mortality: range 15 to 31 days · people with cardiogenic shock or low cardiac output syndrome

Levosimendan showed no clear difference in all‐cause short‐term mortality: range 15 to 31 days compared with dobutamine (low certainty).

1 finding from 1 review